Follow
AK Janmeja
AK Janmeja
Professor
Verified email at mmusolan.org
Title
Cited by
Cited by
Year
Tuberculous lymphadenitis
PR Mohapatra, AK Janmeja
J Assoc Physicians India 57 (6), 585-590, 2009
2062009
Mycobacterium tuberculosis modulates macrophage lipid-sensing nuclear receptors PPARγ and TR4 for survival
S Mahajan, HK Dkhar, V Chandra, S Dave, R Nanduri, AK Janmeja, ...
The Journal of Immunology 188 (11), 5593-5603, 2012
2042012
Guidelines for diagnosis and management of bronchial asthma: Joint ICS/NCCP (I) recommendations
R Agarwal, S Dhooria, AN Aggarwal, VN Maturu, IS Sehgal, V Muthu, ...
Lung India 32 (Suppl 1), S3-S42, 2015
1192015
Genetic polymorphism of the CYP1A1, CYP2E1, GSTM1 and GSTT1 genes and lung cancer susceptibility in a north Indian population
RC Sobti, S Sharma, A Joshi, SK Jindal, A Janmeja
Molecular and cellular biochemistry 266, 1-9, 2004
952004
Psychotherapy improves compliance with tuberculosis treatment
AK Janmeja, SK Das, R Bhargava, BS Chavan
Respiration 72 (4), 375-380, 2005
822005
Quality of life impairment in patients of obstructive sleep apnea and its relation with the severity of disease
N Dutt, AK Janmeja, PR Mohapatra, AK Singh
Lung India 30 (4), 289-294, 2013
712013
Assessment of health-related quality of life in patients with pulmonary tuberculosis under programme conditions
AN Aggarwal, D Gupta, AK Janmeja, SK Jindal
The International Journal of Tuberculosis and Lung Disease 17 (7), 947-953, 2013
712013
Comparative analysis of various cytohistological techniques in diagnosis of lung diseases
S Garg, U Handa, H Mohan, AK Janmeja
Diagnostic cytopathology 35 (1), 26-31, 2007
612007
Association of GSTM1T1 genes with COPD and prostate cancer in north Indian population
H Thakur, L Gupta, RC Sobti, AK Janmeja, A Seth, SK Singh
Molecular biology reports 38, 1733-1739, 2011
512011
CYP1A1 and CYP2D6 polymorphism and risk of lung cancer in a North Indian population
R C. Sobti, S Sharma, A Joshi, S K. Jindal, A Janmeja
Biomarkers 8 (5), 415-428, 2003
512003
Outcome of pulmonary rehabilitation in patients after acute exacerbation of chronic obstructive pulmonary disease
TH Deepak, PR Mohapatra, AK Janmeja, P Sood, M Gupta
Indian J Chest Dis Allied Sci 56 (1), 7-12, 2014
432014
Combined effect of GSTM1, GSTT1 and GSTP1 polymorphisms on histological subtypes of lung cancer
RC Sobti, P Kaur, S Kaur, AK Janmeja, SK Jindal, J Kishan, S Raimondi
Biomarkers 13 (3), 282-295, 2008
392008
Effects of cyclin D1 (CCND1) polymorphism on susceptibility to lung cancer in a North Indian population
RC Sobti, P Kaur, S Kaur, J Singh, AK Janmeja, SK Jindal, J Kishan, ...
Cancer genetics and cytogenetics 170 (2), 108-114, 2006
372006
Treatment outcomes of patients placed on treatment under directly observed therapy short-course (dots)
G Kaur, NK Goel, D Kumar, AK Janmeja, HM Swami, M Kalia
Lung India 25 (2), 75-77, 2008
362008
Joint Indian chest society-national college of chest physicians (India) guidelines for spirometry
AN Aggarwal, R Agarwal, S Dhooria, KT Prasad, IS Sehgal, V Muthu, ...
Lung India 36 (Suppl 1), S1-S35, 2019
352019
Tuberculosis of the parotid gland.
AK Janmeja, SK Das, S Kochhar, U Handa
The Indian journal of chest diseases & allied sciences 45 (1), 67-69, 2003
352003
Pulmonary tuberculosis and mucormycosis co-infection in a diabetic patient
D Aggarwal, J Chander, AK Janmeja, R Katyal
Lung India 32 (1), 53-55, 2015
322015
Evaluation of tuberculosis-associated chronic obstructive pulmonary disease at a tertiary care hospital: a case–control study
D Aggarwal, A Gupta, AK Janmeja, M Bhardwaj
Lung India 34 (5), 415-419, 2017
292017
Acquired drug resistance in tuberculosis in Harayana, India.
AK Janmeja, B Raj
The Journal of the Association of Physicians of India 46 (2), 194-198, 1998
261998
Human xenobiotic nuclear receptor PXR augments Mycobacterium tuberculosis survival
E Bhagyaraj, R Nanduri, A Saini, HK Dkhar, N Ahuja, V Chandra, ...
The Journal of Immunology 197 (1), 244-255, 2016
252016
The system can't perform the operation now. Try again later.
Articles 1–20